The NIVA|HF investigational algorithm uses proprietary venous waveform technology from VoluMetrix to assess otherwise hard-to-obtain cardiovascular metrics. According to study authors, ‘This non-invasive measurement has potential for … prevention of hospital admission in heart failure patients.’ NASHVILLE, Tenn., Nov. 04, 2021 (GLOBE NEWSWIRE) — VoluMetrix, a Nashville-based biotech startup dedicated […]